BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MYD88, Q99836, MYD88D, 4615 AND Treatment
15 results:

  • 1. TGFβR1 inhibition drives hepatocellular carcinoma proliferation through induction of toll-like-receptor signalling.
    Mohamed FEZA; Dewidar B; Lin T; Ebert MP; Dooley S; Meindl-Beinker NM; Hammad S
    Int J Exp Pathol; 2024 Apr; 105(2):64-74. PubMed ID: 38328944
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. myd88 in myofibroblasts enhances nonalcoholic fatty liver disease-related hepatocarcinogenesis via promoting macrophage M2 polarization.
    Liu Y; Chen H; Yan X; Zhang J; Deng Z; Huang M; Gu J; Zhang J
    Cell Commun Signal; 2024 Jan; 22(1):86. PubMed ID: 38291436
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma.
    Wang J; Zhang X; Ma X; Chen D; Cai M; Xiao L; Li J; Huang Z; Huang Y; Lian Y
    J Exp Clin Cancer Res; 2023 Nov; 42(1):303. PubMed ID: 37968706
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Structural characteristics of a novel Bletilla striata polysaccharide and its activities for the alleviation of liver fibrosis.
    Jiang G; Wang B; Wang Y; Kong H; Wang Y; Gao P; Guo M; Li W; Zhang J; Wang Z; Niu J
    Carbohydr Polym; 2023 Aug; 313():120781. PubMed ID: 37182941
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
    Wang G; Zhang X; Cheng W; Mo Y; Chen J; Cao Z; Chen X; Cui H; Liu S; Huang L; Liu M; Ma L; Ma NF
    Cell Death Dis; 2021 Sep; 12(10):891. PubMed ID: 34588420
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A practical guide to laboratory investigations at diagnosis and follow up in Waldenström macroglobulinaemia: recommendations from the Medical and Scientific Advisory Group, Myeloma Australia, the Pathology Sub-committee of the Lymphoma and Related Diseases Registry and the Australasian Association of Clinical Biochemists Monoclonal Gammopathy Working Group.
    Maqbool MG; Tam CS; Morison IM; Simpson D; Mollee P; Schneider H; Chan H; Juneja S; Harvey Y; Nath L; Hissaria P; Prince HM; Wordsworth H; Opat S; Talaulikar D
    Pathology; 2020 Feb; 52(2):167-178. PubMed ID: 31902622
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
    Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/myd88/IκBα axis in hepatocellular carcinoma.
    Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
    Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Liquiritin suppresses UVB‑induced skin injury through prevention of inflammation, oxidative stress and apoptosis through the TLR4/myd88/NF‑κB and MAPK/caspase signaling pathways.
    Li XQ; Cai LM; Liu J; Ma YL; Kong YH; Li H; Jiang M
    Int J Mol Med; 2018 Sep; 42(3):1445-1459. PubMed ID: 29901082
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Effect of ST2825 on the proliferation and apoptosis of human hepatocellular carcinoma cells.
    Deng Y; Sun J; Zhang LD
    Genet Mol Res; 2016 Mar; 15(1):15016826. PubMed ID: 26985932
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-myd88-TAK1-mediated NF-κB and MAPK pathway.
    Wang Y; Tu Q; Yan W; Xiao D; Zeng Z; Ouyang Y; Huang L; Cai J; Zeng X; Chen YJ; Liu A
    Biochem Biophys Res Commun; 2015 Jan; 456(1):373-9. PubMed ID: 25475726
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.
    Fan X; He C; Jing W; Zhou X; Chen R; Cao L; Zhu M; Jia R; Wang H; Guo Y; Zhao J
    Cancer Res; 2015 Jan; 75(1):86-97. PubMed ID: 25398438
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. myd88 adaptor-like (Mal) regulates intestinal homeostasis and colitis-associated colorectal cancer in mice.
    Aviello G; Corr SC; Johnston DG; O'Neill LA; Fallon PG
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G769-78. PubMed ID: 24603458
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Helicobacter pylori cag pathogenicity island (cagPAI) involved in bacterial internalization and IL-8 induced responses via NOD1- and myd88-dependent mechanisms in human biliary epithelial cells.
    Boonyanugomol W; Chomvarin C; Hahnvajanawong C; Sripa B; Kaparakis-Liaskos M; Ferrero RL
    PLoS One; 2013; 8(10):e77358. PubMed ID: 24143223
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.